Literature DB >> 17372902

Cytoplasmic accumulation of connexin32 protein enhances motility and metastatic ability of human hepatoma cells in vitro and in vivo.

Qingchang Li1, Yasufumi Omori, Yuji Nishikawa, Toshiaki Yoshioka, Youhei Yamamoto, Katsuhiko Enomoto.   

Abstract

Connexins have long been believed to suppress tumour development during carcinogenesis by exerting gap junctional intercellular communication (GJIC). Although GJIC is abrogated in hepatocellular carcinoma (HCC), connexin32 (Cx32) protein tends to remain expressed in cytoplasm, but not in cell-cell contact areas; thus, it is incapable of forming gap junctions. Hypothesising that cytoplasmic Cx32 protein that has accumulated in HCC should have its proper functions, which are independent of GJIC, we established an inducible expression system of Cx32 in human HuH7 HCC cells, which were unable to support the formation of Cx32-mediated gap junctions, so that Cx32 protein could be overexpressed by doxycycline (Dox) withdrawal. Although the established clone HuH7 Tet-off Cx32 cells exhibited a 4-fold increase in Cx32 expression after Dox withdrawal, none of them were dye-coupled, and Cx32 protein was retained in the Golgi apparatus. However, the proliferation rate of the HuH7 Tet-off Cx32 cells was significantly higher in the Dox-free medium than in the Dox-supplemented one. Transwell assays also revealed that Dox withdrawal enhanced serum-stimulated motility and invasiveness into Matrigel of the HuH7 Tet-off Cx32 cells. Furthermore, when HuH7 Tet-off Cx32 cells were xenografted into the liver of SCID mice, only the mice to which no Dox was administered developed metastatic lesions, indicating that overexpression of cytoplasmic Cx32 protein induced metastasis of HuH7 cells. Our results suggest that, while Cx32-mediated GJIC suppresses the development of HCCs, cytoplasmic Cx32 protein exerts effects favourable for HCC progression, such as invasion and metastasis, once the cells have acquired a malignant phenotype. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372902     DOI: 10.1002/ijc.22696

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

Review 1.  Physiological and physiopathological aspects of connexins and communicating gap junctions in spermatogenesis.

Authors:  Georges Pointis; Jérome Gilleron; Diane Carette; Dominique Segretain
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

Review 2.  Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.

Authors:  Kannan Badri Narayanan; Manaf Ali; Barry J Barclay; Qiang Shawn Cheng; Leandro D'Abronzo; Rita Dornetshuber-Fleiss; Paramita M Ghosh; Michael J Gonzalez Guzman; Tae-Jin Lee; Po Sing Leung; Lin Li; Suidjit Luanpitpong; Edward Ratovitski; Yon Rojanasakul; Maria Fiammetta Romano; Simona Romano; Ranjeet K Sinha; Clement Yedjou; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Dustin G Brown; Elizabeth P Ryan; Annamaria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Hosni K Salem; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Seo Yun Kim; William H Bisson; Leroy Lowe; Hyun Ho Park
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 3.  Implications and challenges of connexin connections to cancer.

Authors:  Christian C Naus; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

Review 4.  Gap junction and hemichannel-independent actions of connexins on cell and tissue functions--an update.

Authors:  Jade Z Zhou; Jean X Jiang
Journal:  FEBS Lett       Date:  2014-01-14       Impact factor: 4.124

5.  Connexin 32 increases the proliferative response of Schwann cells to neuregulin-1 (Nrg1).

Authors:  Mona Freidin; Samantha Asche; Thaddeus A Bargiello; Michael V L Bennett; Charles K Abrams
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

Review 6.  Connexin 43 a check-point component of cell proliferation implicated in a wide range of human testis diseases.

Authors:  Daniel Chevallier; Diane Carette; Dominique Segretain; Jérome Gilleron; Georges Pointis
Journal:  Cell Mol Life Sci       Date:  2012-08-24       Impact factor: 9.261

Review 7.  Pathological significance of intracytoplasmic connexin proteins: implication in tumor progression.

Authors:  Yasufumi Omori; Qingchang Li; Yuji Nishikawa; Toshiaki Yoshioka; Masayuki Yoshida; Takuya Nishimura; Katsuhiko Enomoto
Journal:  J Membr Biol       Date:  2007-07-27       Impact factor: 1.843

8.  Hepatic gap junctions in the hepatocarcinogen-resistant DRH rat.

Authors:  Takahiro Gotow; Motoko Shiozaki; Taneaki Higashi; Kentaro Yoshimura; Masahiro Shibata; Eiki Kominami; Yasuo Uchiyama
Journal:  Histochem Cell Biol       Date:  2008-07-17       Impact factor: 4.304

9.  The effect of the PQ1 anti-breast cancer agent on normal tissues.

Authors:  Ying Ding; Keshar Prasain; Thi D T Nguyen; Duy H Hua; Thu Annelise Nguyen
Journal:  Anticancer Drugs       Date:  2012-10       Impact factor: 2.248

Review 10.  Connexin and pannexin signaling in gastrointestinal and liver disease.

Authors:  Michaël Maes; Sara Crespo Yanguas; Joost Willebrords; Bruno Cogliati; Mathieu Vinken
Journal:  Transl Res       Date:  2015-05-16       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.